Director Julia Haller resigns from Outlook Therapeutics board, effective March 11, 2026

Outlook Therapeutics, Inc.

Dr. Julia Haller resigned as Class II director, also serving on Nominating and Corporate Governance Committee.
Board accepted resignation on March 6, 2026, effective March 11, with board size reduced to nine.
Resignation not due to any dispute with company; she cited new CEO duties at Wills Eye Hospital.
Company thanked Dr. Haller for her contributions during her tenure.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.